PubMed Health⌕ Search

Biomedical subjects

R T Kung

Publications and source records attributed to R T Kung.

25 records · Page 2Linked to original sources

Development of an efficient electrohydraulic total artificial heart.

The efficient use of space and energy is achieved in a new implantable total artificial heart (TAH). To fit the orthotopic thoracic space, toroidal blood pumps encircle an energy converter, consisting of a centrifugal hydraulic fluid pump and a rotary reversing valve. The new centrifugal pump produces cardiac outputs of 6 L/min, with an average hydraulic efficiency of 47%. Toroidal blood pumps encircling the pump deliver a 60 cc stroke with an 85% ejection fraction and have a predictable blood flow pattern with no stagnant regions. Components have been characterized in vitro, and blood contacting elements have been tested in vivo.

Blood Flow Velocity↗

Device reliability.

Explore the source record for details and available documents.

Artificial Organs↗

An atrial hydraulic shunt in a total artificial heart. A balance mechanism for the bronchial shunt.

An implantable TAH must be able to maintain physiologic atrial pressures over a range of left side shunt flows, which in humans can range up to 5% of the total cardiac output (CO). The authors describe the characteristics of an atrial hydraulic shunt in an electrohydraulic TAH. A small (10 cc stroke) chamber placed in line between the left atrial cuff and the inflow valve is shunted to the right hydraulic chamber. High left atrial pressure increases the volume displaced by this chamber; this concurrently reduces the right chamber stroke volume and flow relative to the left side. For left atrial pressures (LAP) between 0 and 15 mmHg, CO increased from approximately 3 to > 9 L/min (Starling-like behavior). This was attainable with bronchial flow settings between 0.2 to 0.7 L/min, satisfying physiologic needs. Left atrial pressure and RAP (right atrial pressure) tracked each other. The mean difference, LAP-RAP, remained within 5 mmHg at low filling pressures and approached 0 mmHg difference at high filling pressures. The results showed that the atrial hydraulic shunt method can adequately compensate for and manage physiologic left-right flow differences.

Animals↗

A compact and noise free electrohydraulic total artificial heart.

The ABIOMED total artificial heart (TAH) is designed for long-term tether-free use in patients with end-stage heart disease. Blood pumping is achieved through hydraulic fluid motion across flexing diaphragms. The hydraulic power is derived from a miniature centrifugal pump (50% efficiency). Flow directional change needed for alternate left and right filling and ejection is achieved with a rotary valve. With no mechanical contact with the flexing membrane, the wedge angle between the two pumps sandwiching the energy convertor can be easily optimized for anatomic fit. The blood pumps (80 ml strokes) are fitted with trileaflet polyetherurethane valves (24 mm). The TAH is implanted using twist-lock stepless quick connectors to the inflow cuffs and outflow grafts. Left-right flow balance is achieved with an atrial hydraulic shunt placed between the left cuff and inflow valve. Animal studies show that the TAH fits very well in Long Horn calves weighing 90 to 100 kg and can provide cardiac output in excess of 10 L/min. A cadaver (85 kg) study showed the TAH fits within the pericardial region.

Adult↗

Life testing of implantable batteries for a total artificial heart.

Although lithium cells may promise to be ideal as a rechargeable internal battery for a TAH, NiCd cells remain the most easily accessible off the shelf energy source. Twelve 1.2 A.hr prismatic NiCd (Sanyo, San Diego, CA) cells in series are being tested under the load condition of our TAH. The load consisted of a 1.5 A DC current with 1 A pulses of 40 msec duration at 3.33 Hz (100 bpm), a condition that can generate up to 8 L/min of cardiac output at physiologic pressures. Cells were tested at 37 degrees C. Cell voltages and temperatures were monitored. Testing was accelerated to five charge/discharge cycles per day. Discharge was terminated when any one cell dropped below 1.1 V. Charging (C/4) was continued until the battery voltage indicated a change in slope. Cell temperatures remained below 42 degrees C throughout the charge/discharge cycle. The battery pack settled to a nearly constant capacity of over 25 min after 10 cycles and has accumulated more than 1,000 cycles. Voltage differences among cells were small (SD < 25 mV), indicating consistency among cells. NiCd cells can serve as a reliable interim for TAH internal battery application.

Cadmium↗

A tubular pediatric ventricular assist device. Design considerations and system characteristics.

A clinical need exists for the short-term use of pediatric ventricular assist device in children and small infants who are critically ill with heart failure unresponsive to pharmacologic support or, in the case of irreversible heart failure, as a bridge to a transplant device. The design considerations and device characteristics of a tubular pump are presented. The device consists of an integrally formed inflow valve, pump chamber, and outflow valve in a tubular construction. This design approach was selected due to its simplicity of fabrication, which can result in a reliable and low cost device. The inflow valve and pump are actuated pneumatically through a single drive line. The outflow valve can be either actively actuated or operated passively. A 5 ml stroke volume device was built and characterized in vitro and in vivo. This pump can generate 0.5 L/min at 100 beats per minute. Larger stroke volume devices can be and have been fabricated using the same principle.

Algorithms↗